References
- Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA. 2015;314(17):1818-31.
- LAREB DD. Update overview 2019 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab.: LAREB; 2019 https://databankws.lareb.nl/Downloads/Signals_2019_DOACs_update_overview%202019.pdf
- Lepore ML. Upper airway obstruction induced by warfarin sodium. Arch Otolaryngol. 1976;102(8):505-6.
- Gonzalez-Garcia R, Schoendorff G, Munoz-Guerra MF, Rodriguez-Campo FJ, Naval-Gias L, Sastre-Perez J. Upper airway obstruction by sublingual haematoma : a complication of anticoagulation therapy with acenocoumarol. Am J Otolaryngol. 2006;27(2):129-32.
- Cashman E, Shandilya M, Amin M, Hughes J, Walsh M. Warfarin-induced sublingual haematoma mimicking Ludwig angina: Conservative management of a potentially life-threatening condition. Ear Nose Throat J. 2011;90(2):E1.
- Frohna WJ, Lowery RC, Jr., Pita F. Lingual and sublingual haematoma causing upper airway obstruction. J Emerg Med. 2012;43(6):1075-6.
- Puri A, Nusrath MA, Harinathan D, Lyall J. Massive sublingual haematoma secondary to anticoagulant therapy complicated by a traumatic denture: a case report. J Med Case Rep. 2012;6:105.
- Lovallo E, Patterson S, Erickson M, Chin C, Blanc P, Durrani TS. When Is “Pseudo-Ludwig’s Angina” Associated With Coagulopathy Also a “Pseudo” Hemorrhage? J Investig Med High Impact Case Rep. 2013;1(2):2324709613492503.
- Pathak R, Supplee S, Aryal MR, Karmacharya P. Warfarin induced sublingual haematoma : a Ludwig angina mimic. Am J Otolaryngol. 2015;36(1):84-6.
- Almegren M. Reversal of direct oral anticoagulants. Vasc Health Risk Manag. 2017;13:287-92.
- Palaiodimos L, Miles J, Kokkinidis DG, Barkolias C, Jonnalagadda AK, Papaconstantinou D, et al. Reversal of Novel Anticoagulants in Emergent Surgery and Trauma: A Comprehensive Review and Proposed Management Algorithm. Curr Pharm Des. 2018;24(38):4540-53.
- Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014;63(20):2141-7.
- Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-104.
- Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, et al. Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation. 2013;128(21):2325-32.
- Cowell RP. Direct oral anticoagulants: integration into clinical practice. Postgrad Med J. 2014;90(1067):529-39.
- Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, et al. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554-62.
- Greinacher A, Thiele T, Selleng K. Reversal of anticoagulants: an overview of current developments. Thromb Haemost. 2015;113(5):931-42.
- Karmacharya P, Pathak R, Ghimire S, Shrestha P, Ghimire S, Poudel DR, et al. Upper Airway Haematoma Secondary to Warfarin Therapy: A Systematic Review of Reported Cases. N Am J Med Sci. 2015;7(11):494-502.